Breaking News
October 21, 2017 - New Genes Linked to Restless Legs Syndrome
October 21, 2017 - No relief in sight for those suffering from sciatica
October 21, 2017 - 'This Is About Saving Lives': What We Heard This Week
October 21, 2017 - 3 Million Americans Say They Carry Handguns Every Day
October 21, 2017 - Night shift work linked to an increased risk of obesity
October 21, 2017 - Avoiding Alcohol Helps the Heart Beat Better
October 21, 2017 - Exposure to heavy metals may increase risk of autism
October 21, 2017 - Derms: Oral Contraceptives as Acne Tx Warrant Caution
October 21, 2017 - How Foods Labeled 'Healthy' Can Still Make You Fat
October 21, 2017 - ALS patient behind ice bucket challenge: I will bounce back
October 21, 2017 - FDA Advisory Committee Unanimously Recommends Approval of Investigational Luxturna (voretigene neparvovec) for Patients with Biallelic RPE65-mediated Inherited Retinal Disease
October 21, 2017 - Household bleach may raise chronic lung disease risk
October 21, 2017 - Patient Care vs Primary Care: Is There a Problem Here?
October 21, 2017 - State Laws Help Reduce Concussions in Youth Sports
October 21, 2017 - Study indicates proof of concept for using a surrogate liquid biopsy to provide genetic profile of retinoblastoma tumors
October 21, 2017 - Story-based videos hold promise for encouraging Latinas to seek help for anxiety and depression
October 21, 2017 - Study identifies predictors of poor outcomes in Duchenne muscular dystrophy patients
October 21, 2017 - New study explores how herpes simplex virus may change during familial transmission
October 21, 2017 - Researchers analyze frequency of mislabeling in herbal and dietary supplements
October 21, 2017 - Direct‐acting antiviral therapy linked to 71% reduction in liver cancer risk
October 21, 2017 - NAFLD linked to higher cardiovascular risk in women, but not in men
October 21, 2017 - Study finds increasing health care costs for patients with alcoholic cirrhosis
October 21, 2017 - Liver cirrhosis mortality found to be greater than that of five major cancers
October 21, 2017 - VUMC reaches new milestone after performing 2,000th liver transplant
October 21, 2017 - Study examines risk of using liver organs from hepatitis C positive donors
October 21, 2017 - Daily aspirin therapy linked to reduced risk of HBV‐related liver cancer
October 21, 2017 - Increased use of split liver transplantation could decrease pediatric waitlist deaths
October 21, 2017 - HCV screening or diagnosis could lower non‐prescribed opioid use
October 21, 2017 - Schizophrenia Affects Brain's Communication Network
October 21, 2017 - Serum metabolites linked to NAFLD may be heritable, research shows
October 21, 2017 - Pneumoconiosis: Symptoms, risk factors, and management
October 21, 2017 - Study finds rise in pregnancy rates among women with chronic liver disease
October 21, 2017 - 1 in 5 Young Women Who Tan Indoors Get Addicted
October 21, 2017 - Stent Outcomes Not So Different Across Sexes, Races
October 21, 2017 - Eyebank corneal tissue prep may increase infection risk
October 21, 2017 - Researchers use nanopore technique to detect biomarkers of disease
October 21, 2017 - UC San Diego researchers develop 3D visualization tool for mapping omics data onto organs
October 21, 2017 - Umass Amherst scientist receives grant to study pollutant effects on embryos in animal models
October 21, 2017 - Study finds rising incidence of IBD in newly industrialized countries
October 21, 2017 - Researchers use novel imaging technique for precise assessment of spinal degeneration
October 21, 2017 - Penn State receives federal grant to improve services for children with complex communication needs
October 21, 2017 - New synthetic genetic tool measures and manipulates protein aggregation in live cells
October 21, 2017 - Introduction of childbirth guide results in fewer stillbirths at East African hospital
October 21, 2017 - New vaccine for pneumonia holds promise to save thousands of lives
October 21, 2017 - Study provides deeper understanding on mechanisms of lipid-based autoimmune disease
October 21, 2017 - Pharmacological stimulation of nicotinic receptor could be strategy to treat lung inflammation
October 20, 2017 - Parents with alcohol use disorder increase risk for teen dating violence
October 20, 2017 - Inventiva’s Phase IIb FASST Trial in Systemic Sclerosis with Lanifibranor Completes Enrollment
October 20, 2017 - Torn meniscus: Causes, symptoms, and recovery
October 20, 2017 - Post-Mastectomy Breast Reconstruction Gains Ground
October 20, 2017 - Self-Harm on the Rise Among Teen Girls
October 20, 2017 - Mice delivered by C-section gain more weight than those delivered naturally
October 20, 2017 - Novo Nordisk Receives Positive 16-0 vote from FDA Advisory Committee in Favor of Approval for Semaglutide
October 20, 2017 - Shy bladder: Causes and treatments
October 20, 2017 - Obese Kids with Asthma at Higher Risk for Hospital Readmission
October 20, 2017 - Could Too Much Exercise Be Bad for Men's Hearts?
October 20, 2017 - Oxidative stress produces damage linked with increased risk of preterm birth
October 20, 2017 - Gene circuit can be used to switch on inside cancer cells and stimulate immune attack, study suggests
October 20, 2017 - Health Tip: Best Grains And Starchy Veggies for Diabetics
October 20, 2017 - Alzheimer's could be diagnosed early with sniff tests
October 20, 2017 - CardioBrief: Imaging Offers Insight Into Inflammation in CV Disease
October 20, 2017 - More Young Kids Spending Lots of Time on Phones, Tablets
October 20, 2017 - Study provides insights into how amygdala regulates emotions and social behavior
October 20, 2017 - Chromosomes may be entangled, research finds
October 20, 2017 - Experts create quality improvement blueprint to reduce repetitive lab tests for hospitalized patients
October 20, 2017 - Researchers discover new function in gene-regulatory protein
October 20, 2017 - Findings suggest e-cigarettes may be just as bad as traditional cigarettes
October 20, 2017 - Adipose-derived stem cell clinical trial focuses on non-healing leg wounds
October 20, 2017 - Incysus Announces FDA Approval of IND Application for a Phase I Study of a Gamma-Delta (γδ) T Cell Leukemia and Lymphoma Immunotherapy
October 20, 2017 - Dust mite allergy: Symptoms, treatment, and prevention
October 20, 2017 - FDA's Patient Engagement Committee Launches
October 20, 2017 - Arthritis Can Strike Children
October 20, 2017 - Study shows people find well-being more so from special places than from mementoes
October 20, 2017 - Suspected plague cases from Seychelles tested negative at WHO partner laboratory
October 20, 2017 - UGA researchers pinpoint factors that drive sharp rise in breast cancer genetic testing
October 20, 2017 - New study reveals extensive healthcare costs that result from acute kidney injury
October 20, 2017 - Amid for-profit surge, rural hospice has offered free care for 40 years
October 20, 2017 - Teens' increased use of electronic devices linked to rise in insufficient sleep
October 20, 2017 - Delayed word processing could indicate MCI patients’ likelihood of developing Alzheimer's
October 20, 2017 - Researchers reveal how certain nerves sustain prostate cancer growth
Ebola vaccine that provides a year’s worth of protection developed

Ebola vaccine that provides a year’s worth of protection developed

image_pdfDownload PDFimage_print

Liberia’s Ebola outbreak has yielded a successful trial of two vaccines against the deadly infection that could provide protection for up to a year and is also deemed to be safe.

Microscopic view of Ebola Virus. Image Credit: Nixx Photography / Shutterstock

Microscopic view of Ebola Virus. Image Credit: Nixx Photography / Shutterstock

The results come from US-Liberian clinical research partnership. It was in October 2014 that Liberia, which was hard hit with Ebola outbreaks, had asked US health officials for research support to help fight the outbreak. This was the beginning of Partnership for Research on Ebola Virus in Liberia (PREVAIL) that finally led to this vaccine. The results of the study are published in the latest issue of the New England Journal of Medicine this week.

The latest trial of these vaccines started off in February 2015. They had planned a phase 3 trial which means, they had planned initially to recruit many people (around 28,000 volunteers) for this study. As the disease activity sharply declined, they had to step down to a phase 2 study with a smaller number of participants (around 1,500).

The team of researchers compared the two vaccine candidates with saline placebo injection. The vaccines tried were;

  • An adenovirus-based vaccine (ChAd3) developed by the National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline
  • A recombinant vesicular stomatitis virus-based vaccine (VSV-EBOV) developed by researchers in Canada and now licensed by Merck

VSV-EBOV has been already tried in Guinea in the spring and summer of 2015 and showed efficacy in protecting people who received it soon after exposure to Ebola. It helped curb the Ebola flare ups in different parts of West Africa.

This latest trial was sponsored by NIAID, part of the National Institutes of Health (NIH). Around 1500 people were included in the study. These adults had never been previously exposed to Ebola. They received either of the two vaccines or the saline injection. Their blood samples were then gathered and tested at four points after the injection – 1 week, 1 month, 6 months and 1 year. At the one year testing, the blood showed a modest antibody response to the virus causing Ebola. The titres or levels of antibodies that provide the specific protection against an infection by the end of a month after the injection was seen to be four times greater than before they received the injection in 71 percent of those who received ChAd3 and 84 percent of those who received VSV-EBOV. These levels were seen in only 3 percent of those who received saline shots. At end of one year the antibody response was maintained for 64 percent, 80 percent and 7 percent in the ChAd3, VSV-EBOV and saline placebo groups respectively.

Side effects of the vaccines include headache, muscle aches, fever and tiredness. These side effects were seen in earlier trials as well for both of these vaccines and no major new safety red flags were seen. Some other findings from this study include the fact that those who received this vaccine also seemed to have a lower rate of getting malaria especially those who received the VSV-EBOV shots. This might be due to some “cross immunity” which needs to be explored in further research said the team. In addition, around 4 percent of the population already had some immunity against Ebola virus before they received the shots found researchers.

Further studies about the effectiveness of these vaccines in children is necessary wrote the team since around 16 percent of the infected persons are children.

Reference:

0a4b0fba-aed0-48d5-b15e-c0112865f26c|0|.0

Posted in: Medical Research News | Disease/Infection News

Tags: Adenovirus, Allergy, Antibodies, Antibody, Blood, Children, Ebola Virus, Fever, Headache, Infectious Diseases, Malaria, Muscle, Placebo, Stomatitis, Vaccine, Virus

Tagged with:

About author

Related Articles